Autobacsven vs CSR Which Should You Buy?
Autobacsven and CSR stocks are two distinct investment options within the financial market. Autobacsven, a leading automotive retailer, offers investors the opportunity to capitalize on the growing demand for automotive products and services. On the other hand, CSR stocks represent companies that prioritize corporate social responsibility and sustainable practices, appealing to socially-conscious investors. Both investment options offer unique benefits and considerations, making them popular choices for investors seeking to diversify their portfolios and align with their financial and ethical goals.
Autobacsven or CSR?
When comparing Autobacsven and CSR, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Autobacsven and CSR.
Dividend Investors:
Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company.
Autobacsven has a dividend yield of 2.78%, while CSR has a dividend yield of 1.34%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Autobacsven reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, CSR reports a 5-year dividend growth of 5.72% year and a payout ratio of 72.34%.
Value Investors:
Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Autobacsven P/E ratio at 39.44 and CSR's P/E ratio at 18.53. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Autobacsven P/B ratio is 0.88 while CSR's P/B ratio is 3.37.
Growth Investors:
Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Autobacsven has seen a 5-year revenue growth of 0.14%, while CSR's is 0.13%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Autobacsven's ROE at 2.22% and CSR's ROE at 18.93%.
Retail Investors:
Retail investors often consider stock affordability and company familiarity. For example, day low prices are ¥1438.00 for Autobacsven and A$8.96 for CSR. Over the past year, Autobacsven's prices ranged from ¥1381.50 to ¥1681.00, with a yearly change of 21.68%. CSR's prices fluctuated between A$5.05 and A$8.97, with a yearly change of 77.62%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.